Wealth Enhancement Advisory Services’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.52M Buy
56,083
+8,163
+17% +$1.69M ﹤0.01% 1417
2026
Q1
$1.69M Buy
47,920
+41,044
+597% +$10.2M ﹤0.01% 1491
2025
Q4
$1.92M Sell
6,876
-31,153
-82% -$7.97M ﹤0.01% 1534
2025
Q3
$10.8M Buy
38,029
+31,611
+493% +$8.63M 0.02% 630
2025
Q2
$1.65M Sell
6,418
-2,831
-31% -$675K ﹤0.01% 1462
2025
Q1
$2.07M Sell
9,249
-20,300
-69% -$4.74M ﹤0.01% 1228
2024
Q4
$6.76M Buy
29,549
+22,278
+306% +$5.36M 0.01% 696
2024
Q3
$1.77M Buy
7,271
+1,893
+35% +$423K ﹤0.01% 1116
2024
Q2
$1.03M Buy
5,378
+274
+5% +$55.6K ﹤0.01% 1266
2024
Q1
$1.01M Buy
5,104
+923
+22% +$169K ﹤0.01% 1232
2023
Q4
$719K Buy
4,181
+1,123
+37% +$173K ﹤0.01% 1307
2023
Q3
$452K Buy
+3,058
New +$553K ﹤0.01% 1490
2023
Q1
Sell
-19,157
Closed -$2.86M 554
2022
Q4
$2.86M Sell
19,157
-4,919
-20% -$1.08M 0.04% 155
2022
Q3
$3.13M Sell
24,076
-330
-1% -$75.1K 0.04% 145
2022
Q2
$3.35M Sell
24,406
-1,291
-5% -$275K 0.05% 164
2022
Q1
$4.08M Sell
25,697
-2,850
-10% -$689K 0.06% 147
2021
Q4
$4.43M Sell
28,547
-1,066
-4% -$277K 0.06% 125
2021
Q3
$4.69M Buy
29,613
+88
+0.3% +$24.1K 0.07% 110
2021
Q2
$4.44M Sell
29,525
-12,290
-29% -$2.58M 0.07% 106
2021
Q1
$6.68M Buy
41,815
+499
+1% +$100K 0.12% 80
2020
Q4
$6.37M Buy
41,316
+11,610
+39% +$2.31M 0.14% 60
2020
Q3
$3.4M Buy
29,706
+5,325
+22% +$983K 0.09% 81
2020
Q2
$5.01M Buy
24,381
+16,741
+219% +$2.74M 0.14% 59
2020
Q1
$1.21M Buy
+7,640
New +$1.22M 0.04% 164
2018
Q2
Sell
-29,994
Closed -$2.95M 191
2018
Q1
$2.95M Buy
+29,994
New +$2.83M 0.2% 50

Other funds holding RMD

Wealth Enhancement Advisory Services's RMD Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its ResMed (RMD) stake by 17% in Q2 2026, buying an estimated $1.69M and bringing the position to 56,083 shares worth $2.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1417.

Wealth Enhancement Advisory Services first reported a position in RMD in Q1 2018 and has held it in 25 quarters since. The position peaked at $10.8M in Q3 2025. 147 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Wealth Enhancement Advisory Services held 56,083 shares of ResMed worth $2.52M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 8,163 ResMed shares in Q2 2026, an estimated $1.69M.
  • ResMed made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #1417 holding.
  • Wealth Enhancement Advisory Services first reported a position in ResMed in Q1 2018 and has held it in 25 quarters since.
  • Wealth Enhancement Advisory Services's ResMed position peaked at $10.8M in Q3 2025.
  • 147 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.